A Woman With -Associated Monogenic Diabetes Treated Successfully With Repaglinide Monotherapy.

Journal: AACE clinical case reports
Published Date: Dec 16, 2023

Abstract

BACKGROUND/OBJECTIVE: Monogenic diabetes is a rare type of diabetes that is commonly misdiagnosed as type 1 or 2 diabetes mellitus, which adversely impacts patient care. Such cases are particularly challenging given the heterogeneity in presentation and overlap with other types of diabetes. As the sole use of meglitinides, especially repaglinide, to treat -associated monogenic diabetes has been rarely reported in a few other observational studies, we describe a patient who was treated successfully with repaglinide.

Authors

  • Katherine Cuan
    Department of Medicine, Mount Sinai Morningside and Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Ilana R Bass
    Division of Endocrinology, Department of Medicine, Mount Sinai Morningside and Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, New York.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals